SOLIGENIX, INC. — Director's Dealing 2013

Sep 27, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2013-09-25

Reporting Person: HORGAN KEVIN (Chief Medical Officer & Sr. VP)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-25	Stock Option (Right to Buy)	$0.68	A	85000	Acquired	2022-12-04	Common Stock (85000)	Direct

Footnotes

F1: The Issuer granted the stock option on December 5, 2012 (the "Grant Date"), subject to stockholder approval of an amendment to increase in the number of shares available for issuance the Company's 2005 Equity Incentive Plan (the "2005 Plan") under which the stock option was granted. The Issuer's stockholders approved the amendment to the 2005 Plan on September 25, 2013. The stock option vests immediately as to 21,250 shares and vests as at a rate of 5,313 shares on each three (3) month anniversary of the Grant Date.